“Most of the serum PFAS testing in the US has been conducted via the CDC NHANES studies (National Health and Nutrition Examination Survey). NHANES is now an ongoing process and while some PFAS serum concentrations have decreased significantly, other PFAS have only increased.
The need for blood testing will only continue to grow, well past the scope of the Federal government, with ever expanding lists of PFAS replacement and next-generation compounds already being found in the blood of citizens. As additional insight into the toxicological aspects is better understood, current blood testing can provide a snapshot into one’s own PFAS body burden. Even in areas in the US not impacted by industrial PFAS contamination, the food and water consumed can have a significant impact on the level of serum PFAS.
Eurofins PFAS bio-testing is designed to monitor environmental contaminants utilizing isotope dilution, the most robust and respected analytical technique. This technique is paired with a dedicated human serum lab as well as instrumentation specifically reserved for serum samples to ensure rapid and accurate results. Eurofins development of a self-administered PFAS test will allow clients to expedite the testing process by rapidly sampling and shipping samples back to the lab or study coordinator.”